Podcasts

Episode 67 | A/Prof Surein Arulananda: A Masterclass in Career Growth

In this episode, we welcome A/Prof Surein Arulananda, the interim Director of Medical Oncology and Thoracic Oncology Trials Lead at Monash Health.

Episode Summary

In this episode of TOGA’s ‘Conversations in Lung Cancer Research,’ A/Prof Mel Moore interviews A/Prof Surein Arulananda, the interim Director of Medical Oncology and Thoracic Oncology Trials Lead at Monash Health and Convenor at the 2026 TOGA ASM. They discuss his academic background, his unexpected journey into oncology, a fellowship in Boston and MBA in London and his vision for the future of lung cancer treatment.

Speakers

A/Prof Melissa Moore, Medical Oncologist, St Vincent’s Hospital Melbourne
A/Prof Surein Arulananda, Deputy Director of Medical Oncology and Thoracic Oncology trials lead, Monash Health. Adjunct Associate Professor, Monash University

Play Episode 67 | A/Prof Surein Arulananda: A Masterclass in Career Growth

More Podcasts

75 – The Evolving Landscape of ROS1-positive NSCLC

Podcasts
September 4, 2026

Host A/Prof Steven Kao is joined by A/Prof Venessa Chin and Dr Ben Kong,

74 – Prof Zarnie Lwin OAM: Mentorship, Research, and the Future of Lung Cancer Treatment

Podcasts
August 28, 2026

Host A/Prof Mel Moore interviews Prof Zarnie Lwin OAM, University of Queensland; Medical Oncologist at Royal Brisbane and Women’s Hospital and The Prince Charles Hospital.

73 – Smoking Stigma and Lung Cancer Care in the Screening Era

Podcasts
August 14, 2026

A/Prof Gavin Wright sits down with a multidisciplinary panel of experts to tackle the critical and complex issue of smoking-related stigma in lung cancer.

72 – Dr Jazmin Eckhaus: Robotic Innovations and Ethics in Thoracic Surgery

Podcasts
July 31, 2026

Host A/Prof Mel Moore interviews Dr Jazmin Eckhaus, a practising surgeon in the subspecialty of thoracic surgery.

71 – Immunotherapy in Thoracic Cancers: Applying Broad IO Access Across Thoracic Malignancies

Podcasts
June 26, 2026

Host A/Prof Adnan Nagrial leads a panel discussing the clinical implications of the broad PBS listing of ipilimumab and nivolumab in Australia.

70 – Immunotherapy in Thoracic Cancers: From Indication-Based to Biology-Driven

Podcasts
June 19, 2026

Host A/Prof Deme Karikios leads a panel discussion focusing on the recent, groundbreaking broad PBS listing of certain immunotherapy agents in Australia.

Join our community – stay up to date with the latest research, TOGA news and events

The Thoracic Oncology Group of Australasia Limited acknowledges Traditional Owners of Country throughout Australia and recognises the continuing connection to lands, waters and communities. We pay our respect to Aboriginal and Torres Strait cultures; and to Elders past and present.

Contact

PO Box 1103
Thornbury VIC 3071
Ph: +61 3 9087 3550
ABN: 47 641 984 198

TOGA

Quicklinks

Thoracic Oncology Group of Australasia is registered with the Australian Taxation Office as an Income Tax Exempt Charitable Entity. Donations $2 and over are tax deductible.